Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Apellis Pharmaceuticals (APLS) Data Exceeded Expectations, Expect Shares to Fly - Cantor Fitzgerald
-
Apellis Pharmaceuticals (APLS) PT Raised to $54 at Cantor Fitzgerald Ahead of PEGASUS Near-Term Data
-
Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
-
Pre-Open Stock Movers 03/07: (ARQL) (ALSK) (GWRE) Higher; (APVO) (BPI) (KR) Lower (more...)
-
Apellis Pharmaceuticals (APLS) Prices 6M Share Common Offering at $17/Sh
-
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Apellis Pharmaceuticals (APLS) to Offer $75M in Common Stock
-
Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Apellis Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
Apellis Pharmaceuticals (APLS) PT Raised to $57 at Cantor Fitzgerald on SFJ Pharmaceuticals Support
-
Apellis Pharmaceuticals to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Apellis Pharmaceuticals to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference
-
Cantor Fitzgerald Reiterates Overweight on Apellis Pharmaceuticals (APLS) Following R&D Day
-
UPDATE: Cantor Fitzgerald Starts Apellis Pharmaceuticals (APLS) at Overweight
